| PSNL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PSNL shares outstanding history going back to 6/20/2019:
Also see: PSNL Market Cap History PSNL YTD Return |
As of 10/30/2026 Personalis has 108.40 million PSNL shares outstanding. Investors often track the PSNL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PSNL share count trends over time, with 30 historical shares outstanding datapoints presented, dating back to 6/20/2019.

| PSNL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PSNL shares outstanding history going back to 6/20/2019:
Also see: PSNL Market Cap History PSNL YTD Return |
| PSNL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PSNL Historical Shares Outstanding: +19.88% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PSNL Stock Price Chart |
| About Personalis Inc |
| Personalis, Inc. is engaged in developing and marketing advanced cancer genomic tests and analytics. Co.'s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other next generation cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. We show 30 historical shares outstanding datapoints in our coverage of PSNL's shares outstanding history. Understanding the changing numbers of PSNL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PSNL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PSNL by allowing them to research PSNL shares outstanding history as well as any other stock in our coverage universe. |
| PSNL Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| PSNL Share Performance |
| Shares Outstanding Peers |
| Personalis (PSNL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PSTI Shares Outstanding History PSTV Shares Outstanding History PSTX Shares Outstanding History PTCT Shares Outstanding History PTE Shares Outstanding History PTGX Shares Outstanding History PTI Shares Outstanding History PTIE Shares Outstanding History PTIX Shares Outstanding History PTLA Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.